Transcat’s (NASDAQ:TRNS) Q2 CY2026: Strong Sales

Transcat (NASDAQ:TRNS) reported Q2 CY2026 results. Revenue rose 21.6% year on year to $92.95 million, topping Wall Street estimates by 7.4%. Non-GAAP adjusted EPS was $0.51, up 35.1% versus analysts’ consensus and down from $0.59 a year earlier. Analysts expect revenue to grow about 6% over the next 12 months.

Original reporting
Published Aug 4, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transcat’s (NASDAQ:TRNS) Q2 CY2026: Strong Sales — source image
Decision brief

The 30-second read

$TRNSBullishMed
01

Why it matters

Q2 results beat revenue and adjusted EPS expectations, but operating margin fell and the article flags a deceleration in expected revenue growth, suggesting a mixed fundamental setup.

02

Market read

Traders can reassess near-term earnings power and forward growth expectations after the Q2 beat, while monitoring margin trajectory and dilution.

03

What to watch

Share count growth (dilution) and operating margin decline could outweigh the headline EPS beat for valuation and multiple expansion.

Relevance 7/10Novelty 7/10Timing: after-hours/late-day coverage of Q2 CY2026 results (published 2026-08-04 22:00 UTC)

Background

Transcat is a measurement equipment distributor serving pharma, industrial manufacturing, energy, and chemical process industries.

Company-level read

Ticker impact

$TRNSBullishMedium confidence
Context

Transcat reported Q2 CY2026 revenue of $92.95M, up 21.6% YoY, and adjusted EPS of $0.51, beating consensus.

Expected impact

Near-term bias modestly positive, with follow-through dependent on whether investors focus on the beat versus the margin and deceleration signals.

Evidence & confidence

The article provides concrete Q2 outperformance versus estimates, yet highlights operating margin decline (4% vs prior year) and expected revenue growth decelerating to ~6% over the next 12 months.

Market effects

Signals demand resilience in measurement equipment/distribution, but also highlights cost pressure and margin risk for industrials distributors.

Primarily US small/mid-cap industrials sentiment; limited direct regional spillover described.

No explicit global macro or international supply-chain factors cited.

Counterpoint

The beat may be less durable if margin compression persists and forward revenue growth decelerates to ~6% over the next 12 months.

Key entities

  • Transcat

    NASDAQ-listed measurement equipment distributor reporting Q2 CY2026 results.

Related articles

$TRNSMed

TRANSCAT INC (TRNS): Results of Operations and Financial Condition

TRANSCAT INC (TRNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 trns-20260804xex991.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growt

$TRNSHighAI 9/10

Transcat Inc (TRNS) Q4 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion

Transcat’s CEO Jaime Irick said he will apply Lean Six Sigma to improve efficiency, cycle times, customer-facing processes, and innovation. CFO Thomas Barbato noted Q4 service gross margins were pressured by new customer onboarding, expecting normalization in fiscal 2027 H1 and year-over-year margin gains for the full year. He reiterated an M&A push into new geographies, citing a Latin America SCM acquisition in Costa Rica and exploring sites in several US regions; rental is expected to grow low

$TRNSHighAI 9/10

Transcat Q4 Earnings Call Highlights

Transcat (NASDAQ:TRNS) reported fiscal Q4 consolidated revenue up 16% to $89.3M and full-year revenue up 19% to $331.9M, according to management on its earnings call. Service revenue rose 18% (7% organic) and marked 68 straight quarters of YoY service growth; service gross margin was 35.5%. Adjusted Q4 EPS was $0.56; full-year adjusted EPS $1.84. Management expects higher service organic growth in fiscal Q1 vs Q4.

$TRNSHighAI 9/10

Full Transcript: Transcat Q4 2026 Earnings Call - Transcat (NASDAQ: TRNS)

Transcat (NASDAQ:TRNS) reported Q4 FY2026 consolidated revenue of $89.3 million, up 16%, and full-year revenue growth of 19%. Service revenue rose 18% in Q4 and 20% for the year, supporting gross profit up 18% and gross margin expansion of 50 bps. Adjusted EBITDA grew 23% for the full year. The company said its SCM Metrology acquisition expands operations into Latin America.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.